
InDex Pharmaceuticals Holding AB (publ)
SSE:INDEX.ST
0.244 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 294.267 | 344.931 | 428.449 | 53.834 | 126.79 | 83.034 | 125.055 | 193.232 | 6.96 | 43.892 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 294.267 | 344.931 | 428.449 | 53.834 | 126.79 | 83.034 | 125.055 | 193.232 | 6.96 | 43.892 |
Net Receivables
| 0 | 0 | 14.585 | 3.866 | 1.732 | 1.827 | 1.092 | 0.643 | 0.589 | 0.052 |
Inventory
| -2.348 | 0 | 0 | 0 | 0 | -0.01 | -0.016 | 0 | 0 | 0 |
Other Current Assets
| 2.348 | 2.415 | 0.002 | 0.072 | 0.089 | 1.962 | 1.769 | 0.926 | 1.284 | 1.484 |
Total Current Assets
| 296.615 | 347.346 | 443.036 | 57.772 | 128.611 | 85.006 | 126.84 | 194.443 | 8.298 | 45.428 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 2.773 | 3.989 | 2.159 | 3.411 | 0.475 | 0.02 | 0.031 | 0.042 | 0.056 | 0.151 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0.464 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0.464 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | -0.463 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 |
Total Non-Current Assets
| 2.774 | 3.99 | 2.16 | 3.412 | 0.476 | 0.022 | 0.032 | 0.043 | 0.057 | 0.152 |
Total Assets
| 299.389 | 351.336 | 445.196 | 61.184 | 129.087 | 85.028 | 126.872 | 194.486 | 8.355 | 45.58 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 6.744 | 6.561 | 4.497 | 3.023 | 3.153 | 3.55 | 6.568 | 4.822 | 0.885 | 4.411 |
Short Term Debt
| 0.7 | 0.626 | 0.807 | 0.763 | 0.484 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0.014 | 0 | 0.006 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 3.575 | 5.64 | 17.899 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 51.448 | 7.548 | 5.256 | 6.492 | 18.857 | 21.572 | 15.557 | 12.193 | 6.92 | 10.768 |
Total Current Liabilities
| 58.906 | 14.735 | 10.566 | 10.278 | 22.584 | 25.122 | 22.125 | 17.015 | 7.805 | 15.179 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 1.598 | 2.626 | 0.475 | 1.578 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0.016 | 0.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 1.598 | 2.642 | 0.591 | 1.578 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 60.504 | 17.377 | 11.157 | 11.856 | 22.584 | 25.122 | 22.125 | 17.015 | 7.805 | 15.179 |
Equity: | ||||||||||
Preferred Stock
| 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 10.654 | 10.654 | 10.654 | 1.776 | 1.776 | 1.376 | 1.251 | 1.251 | 6.028 | 6.028 |
Retained Earnings
| -635.646 | -540.381 | -440.048 | -337.005 | -279.577 | 0 | 0 | 0 | -5.478 | 24.373 |
Accumulated Other Comprehensive Income/Loss
| -0.001 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 863.877 | 863.686 | 863.433 | 384.557 | 384.304 | 58.53 | 103.496 | 0 | 0 | 0 |
Total Shareholders Equity
| 238.885 | 333.959 | 434.039 | 49.328 | 106.503 | 59.906 | 104.747 | 177.471 | 0.55 | 30.401 |
Total Equity
| 238.885 | 333.959 | 434.039 | 49.328 | 106.503 | 59.906 | 0 | 0 | 0 | 0 |
Total Liabilities & Shareholders Equity
| 299.389 | 351.336 | 445.196 | 61.184 | 129.087 | 85.028 | 126.872 | 194.486 | 8.355 | 45.58 |